- Home
- IDA vs BPMC Comparison
IDA vs BPMC Comparison
Compare IDA & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDA
- BPMC
- Stock Information
- Founded
- IDA 1915
- BPMC 2008
- Country
- IDA United States
- BPMC United States
- Employees
- IDA N/A
- BPMC N/A
- Industry
- IDA Electric Utilities: Central
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- IDA Utilities
- BPMC Health Care
- Exchange
- IDA Nasdaq
- BPMC Nasdaq
- Market Cap
- IDA 6.3B
- BPMC 5.8B
- IPO Year
- IDA N/A
- BPMC 2015
- Fundamental
- Price
- IDA $118.96
- BPMC $101.35
- Analyst Decision
- IDA Buy
- BPMC Buy
- Analyst Count
- IDA 7
- BPMC 18
- Target Price
- IDA $123.14
- BPMC $125.88
- AVG Volume (30 Days)
- IDA 639.1K
- BPMC 789.4K
- Earning Date
- IDA 05-01-2025
- BPMC 05-01-2025
- Dividend Yield
- IDA 2.89%
- BPMC N/A
- EPS Growth
- IDA 12.96
- BPMC N/A
- EPS
- IDA 5.63
- BPMC N/A
- Revenue
- IDA $1,810,154,000.00
- BPMC $562,121,000.00
- Revenue This Year
- IDA $5.60
- BPMC $44.49
- Revenue Next Year
- IDA $9.80
- BPMC $33.04
- P/E Ratio
- IDA $21.15
- BPMC N/A
- Revenue Growth
- IDA 1.37
- BPMC 99.19
- 52 Week Low
- IDA $90.64
- BPMC $73.04
- 52 Week High
- IDA $120.84
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- IDA 58.05
- BPMC 56.34
- Support Level
- IDA $115.00
- BPMC $94.38
- Resistance Level
- IDA $117.94
- BPMC $102.52
- Average True Range (ATR)
- IDA 2.16
- BPMC 3.77
- MACD
- IDA 0.43
- BPMC -0.38
- Stochastic Oscillator
- IDA 97.26
- BPMC 79.29
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.